Literature DB >> 22127615

ACE inhibitor-induced angioedema.

Monali Vasekar1, Timothy J Craig.   

Abstract

Much has been written about hereditary angioedema (HAE) in recent literature; however, the prevalence of angiotensin-converting enzyme inhibitor-induced angioedema (ACEiIA) far exceeds that of HAE. Similarly, multiple therapies have been developed for HAE, yet no definitive therapy is available for ACEiIA. In this article, we discuss the mechanism, prevalence, pathophysiology, and management of ACEiIA, with focus on newer therapies recently approved for HAE and how they may be effective for ACEiIA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22127615     DOI: 10.1007/s11882-011-0238-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  29 in total

1.  Oral angioedema secondary to ACE inhibitors, a frequently overlooked association: case report and review.

Authors:  Miriam Hurst; Marianne Empson
Journal:  N Z Med J       Date:  2006-04-21

2.  Case study. ACE inhibitor-induced angioedema.

Authors:  Martin Quan
Journal:  Clin Cornerstone       Date:  2009

3.  Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Alencia V Woodard-Grice; Amelia C Lucisano; James B Byrd; Elizabeth R Stone; William H Simmons; Nancy J Brown
Journal:  Pharmacogenet Genomics       Date:  2010-09       Impact factor: 2.089

4.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

5.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.

Authors:  A T Waytes; F S Rosen; M M Frank
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

Review 6.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

7.  Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.

Authors:  Aleena Banerji; Sunday Clark; Michelle Blanda; Frank LoVecchio; Brian Snyder; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

8.  Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.

Authors:  N J Brown; W A Ray; M Snowden; M R Griffin
Journal:  Clin Pharmacol Ther       Date:  1996-07       Impact factor: 6.875

Review 9.  Nonallergic angioedema: role of bradykinin.

Authors:  M Bas; V Adams; T Suvorava; T Niehues; T K Hoffmann; G Kojda
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

10.  Increasing hospitalizations due to angioedema in the United States.

Authors:  Robert Y Lin; Shaili N Shah
Journal:  Ann Allergy Asthma Immunol       Date:  2008-08       Impact factor: 6.347

View more
  12 in total

1.  Angioedema associated with the use of angiotensin-converting enzyme inhibitor.

Authors:  Amir M Nia; Fikret Er
Journal:  CMAJ       Date:  2012-07-09       Impact factor: 8.262

Review 2.  ACE Inhibitor-Induced Angioedema: a Review.

Authors:  William J Kostis; Mrinali Shetty; Yuvraj Singh Chowdhury; John B Kostis
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 3.  Anesthetic Management of the Hypertensive Patient: Part I.

Authors:  Russell Yancey
Journal:  Anesth Prog       Date:  2018

4.  Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Cheng Gang; Christopher J Lindsell; Joseph Moellman; Wesley Sublett; Kim Hart; Sean Collins; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

5.  Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

Authors:  Alberto López-Lera; Fátima Sánchez Cabo; Sofía Garrido; Ana Dopazo; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2013-05-20       Impact factor: 4.123

6.  Fresh frozen plasma in the treatment of ACE inhibitor-induced angioedema.

Authors:  Michael Stewart; Ray McGlone
Journal:  BMJ Case Rep       Date:  2012-08-24

7.  Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway.

Authors:  Abdulgafoor Muslim Tharayil; Arshad Hussain Chanda; Hakim Ahmad Shiekh; Mohamed Saad Elkhatib; Mohammed Nayeemuddin; Abdelhafiz Ali Ahmed Alshamandy
Journal:  Qatar Med J       Date:  2014-12-09

8.  Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria.

Authors:  Nicola Bonner; Charlotte Panter; Alan Kimura; Rich Sinert; Joseph Moellman; Jonathan A Bernstein
Journal:  BMC Health Serv Res       Date:  2017-05-22       Impact factor: 2.655

9.  Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England.

Authors:  Abigail L Coughtrie; Claire Doe; Deborah Layton; Saad A W Shakir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-03       Impact factor: 3.738

Review 10.  Drug allergy: causes and desensitization.

Authors:  Richard Warrington
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.